AngioDynamics Inc Market Cap ($495.58 Million)
Market Cap & Net Worth: AngioDynamics Inc (ANGO)
AngioDynamics Inc market cap. AngioDynamics Inc (NASDAQ:ANGO) has a market capitalization of $495.58 Million ($495.58 Million) as of October 31, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11887 globally and #3039 in its home market, demonstrating a -0.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AngioDynamics Inc's stock price $11.99 by its total outstanding shares 41332389 (41.33 Million).
AngioDynamics Inc Market Cap History (2015–2026)
AngioDynamics Inc market cap history from 2015 to 2026. Data shows change from $501.78 Million to $495.58 Million (-0.35% CAGR). Check current stock price of AngioDynamics Inc for real-time trading data and today's change.
Index Memberships
AngioDynamics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.02% | #328 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #1206 of 3165 |
Weight: AngioDynamics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
AngioDynamics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AngioDynamics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see AngioDynamics Inc (ANGO) cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
1.55x
AngioDynamics Inc's market cap is 1.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $687.36 Million | $349.64 Million | -$7.05 Million | 1.97x | N/A |
| 2018 | $832.02 Million | $344.29 Million | $16.34 Million | 2.42x | 50.93x |
| 2019 | $661.73 Million | $359.48 Million | $61.34 Million | 1.84x | 10.79x |
| 2020 | $633.63 Million | $264.16 Million | -$166.79 Million | 2.40x | N/A |
| 2021 | $1.14 Billion | $291.01 Million | -$31.55 Million | 3.92x | N/A |
| 2022 | $569.15 Million | $316.22 Million | -$26.55 Million | 1.80x | N/A |
| 2023 | $324.05 Million | $338.75 Million | -$52.44 Million | 0.96x | N/A |
| 2024 | $378.60 Million | $303.91 Million | -$184.35 Million | 1.25x | N/A |
| 2025 | $530.71 Million | $292.50 Million | -$33.99 Million | 1.81x | N/A |
| 2026 | $495.58 Million | $320.17 Million | -$36.74 Million | 1.55x | N/A |
Competitor Companies of ANGO by Market Capitalization
Companies near AngioDynamics Inc in the global market cap rankings as of October 31, 2026. See how leveraged is AngioDynamics Inc's balance sheet to understand what proportion of total assets are financed by equity.
Key companies related to AngioDynamics Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.77 Billion USD ( €85.34 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #421 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #536 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $432.01 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.77 Billion | €184.30 |
| #421 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €87.50 |
| #536 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of AngioDynamics Inc (2015–2026)
Market capitalization of AngioDynamics Inc from 2015 to today. Between 2015 and today, AngioDynamics Inc's market cap moved from $501.78 Million to $ 495.58 Million, with a yearly change of -0.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $495.58 Million | -6.62% |
| 2025 | $530.71 Million | +40.17% |
| 2024 | $378.60 Million | +16.84% |
| 2023 | $324.05 Million | -43.06% |
| 2022 | $569.15 Million | -50.07% |
| 2021 | $1.14 Billion | +79.91% |
| 2020 | $633.63 Million | -4.25% |
| 2019 | $661.73 Million | -20.47% |
| 2018 | $832.02 Million | +21.05% |
| 2017 | $687.36 Million | -1.42% |
| 2016 | $697.28 Million | +38.96% |
| 2015 | $501.78 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of AngioDynamics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $495.58 Million USD |
| MoneyControl | $495.58 Million USD |
| MarketWatch | $495.58 Million USD |
| marketcap.company | $495.58 Million USD |
| Reuters | $495.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vesse… Read more